scholarly journals Efficacy and safety testing of mycotoxin-detoxifying agents in broilers following the European Food Safety Authority guidelines

2012 ◽  
Vol 91 (8) ◽  
pp. 2046-2054 ◽  
Author(s):  
A. Osselaere ◽  
M. Devreese ◽  
A. Watteyn ◽  
V. Vandenbroucke ◽  
J. Goossens ◽  
...  
Molecules ◽  
2021 ◽  
Vol 26 (7) ◽  
pp. 2095
Author(s):  
Pedro Estevan Navarro ◽  
Isabel Sospedra ◽  
Alejandro Perales ◽  
Cristina González-Díaz ◽  
Rubén Jiménez-Alfageme ◽  
...  

Caffeine is a food supplement widely consumed by athletes, but it has not been established. So far, the veracity of their labeling in terms of the dosage and cause/effect relationship aimed at the consumer. The aim is to analyze the health claims and the dosage presented on the labeling of caffeine supplements and to evaluate if they follow the European Food Safety Authority (EFSA) and international criteria. A descriptive cross-sectional study of a sample of caffeine supplements was carried out. The search was done through the Amazon and Google Shopping web portals. In order to assess the adequacy of the health claims, the guidelines of reference established by European Food Safety Authority were compared to the Academy of Nutrition and Dietetics, International Olympic Committee, and Australian Institute of Sport guidelines; in addition, recent systematic reviews were addressed. A review of labels of 42 caffeine supplements showed that, in less than 3% of the products were the health claims supported by the recommendations and by the labeled quantity of caffeine. The claims that fully complied the recommendations were, “improves or increases endurance performance”, “improves strength performance”, or “improves short-term performance”. In most cases, the recommended dosage was 200 mg/day for these products, which is the minimum for the caffeine effects to be declared. The rest of the health claims were not adequate or need to be modified. Most of the health claims identified indicated an unproven cause and effect, which constitutes consumer fraud, and so must be modified or eliminated.


2017 ◽  
Vol 19 (3) ◽  
pp. 168-182
Author(s):  
Caer Smyth

In 2015, the International Agency for Research on Cancer of the World Health Organisation published a monograph stating that glyphosate, the active ingredient in Roundup, Monsanto’s leading herbicide, was ‘probably carcinogenic to humans’. Shortly after this, the European Food Safety Authority re-assessed glyphosate’s licence for use in the European Union, and deemed it to be safe for human use. Both of these expert advisory bodies faced condemnation and accusations of political bias as a result of these assessments. Employing Jasanoff’s ‘three-body problem’, this article examines the conflicting conclusions of the International Agency for Research on Cancer and the European Food Safety Authority, exploring what the contested assessments of glyphosate reveal about the entangled relationship between scientific expertise and law-making.


F1000Research ◽  
2016 ◽  
Vol 4 ◽  
pp. 1422 ◽  
Author(s):  
Kevin McKernan ◽  
Jessica Spangler ◽  
Lei Zhang ◽  
Vasisht Tadigotla ◽  
Yvonne Helbert ◽  
...  

The Center for Disease Control estimates 128,000 people in the U.S. are hospitalized annually due to food borne illnesses. This has created a demand for food safety testing targeting the detection of pathogenic mold and bacteria on agricultural products. This risk extends to medicalCannabisand is of particular concern with inhaled, vaporized and even concentratedCannabisproducts.As a result, third party microbial testing has become a regulatory requirement in the medical and recreationalCannabismarkets, yet knowledge of theCannabismicrobiome is limited. Here we describe the first next generation sequencing survey of the fungal communities found in dispensary basedCannabisflowers by ITS2 sequencing, and demonstrate the sensitive detection of several toxigenicPenicilliumandAspergillusspecies, includingP. citrinum and P. paxilli,that were not detected by one or more culture-based methods currently in use for safety testing.


2021 ◽  
Vol 233 ◽  
pp. 02029
Author(s):  
Xindi Zhang

Economic development has not only led to the steady development of the gross national economy, but also provided a fundamental guarantee for the life of the residents at this stage. However, with the rapid development of economy, people’s attention to hidden safety problems has gradually shifted from big problems to “small details” of food safety. At the same time, in order to reduce the health problems of consumers in the process of eating products, we should start from the source of food, and use microbial technology in the current food safety testing, so as to fundamentally improve the quality of food safety. At present, PCR, impedance, ATP bioluminescence, lamp and enzyme-linked immunosorbent assay are widely used. In this paper, the role of microbial detection technology was described, and the application of microbial detection technology in food safety detection was analyzed in depth, hoping to provide a reference for ensuring food safety through the promotion of microbial detection technology.


2016 ◽  
Vol 70 (8) ◽  
pp. 741-745 ◽  
Author(s):  
Christopher J Portier ◽  
Bruce K Armstrong ◽  
Bruce C Baguley ◽  
Xaver Baur ◽  
Igor Belyaev ◽  
...  

2012 ◽  
Vol 3 (2) ◽  
pp. 85-89 ◽  
Author(s):  
M.B. Katan

Probiotics are microbes that are claimed to promote health and well-being when added to foods. However, the European Food Safety Authority (EFSA) has so far advised negatively about health claims for probiotics. Companies and scientists have protested against these rejections, sometimes in vigorous language. I argue that EFSA could not have acted differently, given EU regulations and the lack of convincing evidence for some of the claimed effects of probiotics on human health and well-being. One EU regulation that makes it hard to demonstrate the benefits of probiotics is the prohibition of medical claims, i.e. claims that a food prevents or cures a disease. If this prohibition did not exist, manufacturers of nutritional treatments might circumvent the costly procedures required for drugs, and market their products to ill people without thorough proof that they are effective and safe. However, the prohibition is also a legal fiction, because promotion of health and prevention of disease is largely the same thing. EFSA has recently indicated that it will allow health claims based on the ability of probiotics to reduce infections. To a certain extent, this abolishes the distinction between health claims and medical claims. It remains to be seen if probiotics producers can convince EFSA that their products prevent or cure infections and other diseases in humans.


Sign in / Sign up

Export Citation Format

Share Document